Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart pump therapy shows promise for long COVID fatigue

NCT ID NCT07492953

First seen Apr 03, 2026 · Last updated May 22, 2026 · Updated 11 times

Summary

This small study tested whether enhanced external counterpulsation (EECP) therapy can improve heart and lung function in adults with long COVID. Ten participants received EECP sessions either one or two hours daily for several weeks. Researchers measured exercise capacity, symptoms, and quality of life to see if the therapy helps ease persistent fatigue and breathing problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID SYMPTOMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Natioanl Denfense Medical University

    Taipei, 114, Taiwan

Conditions

Explore the condition pages connected to this study.